CEL-SCI (CVM) Stock Chart & Stock Price History $2.31 -0.20 (-7.80%) As of 12:54 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsTrendsBuy This Stock CEL-SCI Stock Price Performance The CEL-SCI (CVM) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 93.93%, with a year-to-date return of -80.79%. In the past month, the stock has decreased 73.51%, reflecting recent market activity. As of the latest close, CEL-SCI traded at $2.50 with a market cap of $7.58 million and volume of 280,124 shares. Five years ago, the stock traded at a split-adjusted price of $362.40, representing a 99.36% decrease over that period. At the time, it had a market cap of $526.50 million and a volume of 36,090 shares. Receive CVM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for CEL-SCI and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-8.17%1 Month Performance-73.51%3 Month Performance-76.72%Year-To-Date Performance-80.79%1 Year Performance-93.93%5 Year Performance-99.36% CVM Stock Chart for Thursday, May, 29, 2025 CVM Chart by TradingView CEL-SCI Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/28/2025$2.51$2.50-0.40%$2.54$2.35280,124 shs$7.58 million05/27/2025$2.51$2.51$2.63$2.36502,875 shs$7.61 million05/26/2025$2.51$2.51$2.57$2.40715,232 shs$7.61 million05/23/2025$2.46$2.51+2.03%$2.57$2.40715,232 shs$228.50 million05/22/2025$4.51$2.46-45.45%$2.60$2.322.01 million shs$223.95 million05/21/2025$5.11$4.51-11.74%$5.22$3.85530,795 shs$410.58 million05/20/2025$6.11$5.11-16.42%$6.64$5.11196,240 shs$465.20 million05/19/2025$6.69$6.11-8.61%$6.96$5.99134,893 shs$18.55 million05/16/2025$6.94$6.69-3.59%$7.12$6.3953,800 shs$18.76 million05/15/2025$7.24$6.94-4.10%$7.50$6.6735,548 shs$19.46 million Get the Latest News and Ratings for CVM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for CEL-SCI and its competitors with MarketBeat's FREE daily newsletter. 05/14/2025$7.77$7.24-6.84%$8.09$6.9942,894 shs$20.29 million05/13/2025$7.62$7.77+1.93%$7.81$7.2516,361 shs$21.78 million05/12/2025$7.40$7.62+2.92%$7.67$7.2319,954 shs$21.37 million05/09/2025$7.64$7.40-3.14%$7.73$7.0526,817 shs$20.76 million05/08/2025$7.25$7.64+5.38%$7.65$7.0221,236 shs$21.44 million05/07/2025$7.39$7.25-1.79%$7.57$7.2018,470 shs$20.34 million05/06/2025$7.54$7.39-2.03%$7.74$7.2026,454 shs$20.71 million05/05/2025$7.53$7.54+0.12%$7.80$7.3718,962 shs$21.14 million05/02/2025$7.98$7.53-5.64%$8.10$7.4183,290 shs$21.12 million05/01/2025$8.70$7.98-8.28%$8.84$7.9525,805 shs$22.38 million04/30/2025$8.70$8.70$8.91$8.2519,429 shs$24.40 million04/29/2025$9.12$8.70-4.57%$9.15$8.5527,323 shs$24.40 million04/28/2025$8.71$9.12+4.65%$9.15$8.7323,308 shs$25.57 million Related Companies Sutro Biopharma Stock Chart IGM Biosciences Stock Chart Zura Bio Stock Chart Elutia Stock Chart Vistagen Therapeutics Stock Chart Unicycive Therapeutics Stock Chart InterCure Stock Chart TScan Therapeutics Stock Chart Seres Therapeutics Stock Chart Alto Neuroscience Stock Chart Receive CVM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for CEL-SCI and its competitors with MarketBeat's FREE daily newsletter. This page (NYSE:CVM) was last updated on 5/29/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredMan who predicted $100K Bitcoin sees a huge run coming for another coin …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CEL-SCI Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share CEL-SCI With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
